Web Analytics

3 Latest Announced Rounds

  • $12,500,000
    Seed
    Biotechnology Research
    Dec 19th, 2025
  • $16,000,000
    Seed

    2 Investors

    Marketing Services
    Dec 19th, 2025
  • $1,500,000
    Unknown

    1 Investors

    Technology, Information and Internet
    Dec 19th, 2025
$1,422.52M Raised in 44 Funding Rounds in the past 7 Days - View All

Funding Round Profile

Phialogics - The immune tolerance company

start up
Germany - Frankfurt, Hesse
  • 08/05/2023
  • Pre-Seed
  • $662,970

Our immune checkpoint activators protect patient’s organ tissue.
Unique approach :
- Potential for BEST-in-class super agonist against immune-mediated tissue damage
- High selectivity for active T-cells
- Proof of concept in relevant human in vitro models and mouse model of disease


Related People

Andreas ErnstFounder

Andreas Ernst Germany - ND

Expert in protein engineering with a keen interest in drug development for the treatment of autoimmune diseases.